Malignant thymoma: current status of classification and multimodality treatment. 2003

I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Str. 25, 53105, Bonn, Germany. picasso@uni-bonn.de.

Classification, understanding of the pathophysiology, and treatment options of thymoma have changed during recent years. It is hoped that novel strategies will lead to a survival benefit in these patients. It has become clear that patients with thymoma are best treated with multimodality therapy. In this review, a pathologist, an immunologist, a surgeon, a radiotherapist, a pneumologist, and oncologists discuss the current status of classification and strategies for the treatment of patients with thymoma.

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013945 Thymoma A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed) Carcinoma, Thymic,Carcinomas, Thymic,Thymic Carcinoma,Thymic Carcinomas,Thymomas
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
April 2006, American journal of clinical pathology,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
April 2000, Cancer treatment reviews,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
August 2011, Zentralblatt fur Chirurgie,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
October 2000, Seminars in thoracic and cardiovascular surgery,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
September 1999, Der Unfallchirurg,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
November 1996, Therapeutische Umschau. Revue therapeutique,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
December 1997, The Annals of thoracic surgery,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
March 2005, Current opinion in oncology,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
January 2016, Critical reviews in biomedical engineering,
I G H Schmidt-Wolf, and J K Rockstroh, and H Schüller, and A Hirner, and C Grohe, and H K Müller-Hermelink, and D Huhn
January 2013, Chinese medical journal,
Copied contents to your clipboard!